Version May 2024
| Persistent symptom¶ | Proportion of patients affected by symptom |
| Common physical symptoms | |
| Fatigue | 15 to 87% |
| Dyspnea | 10 to 71% |
| Chest discomfort | 12 to 44% |
| Cough | 17 to 34% |
| Anosmia | 10 to 13% |
| Less common physical symptoms | |
| Joint pain, headache, sicca syndrome, rhinitis, dysgeusia, poor appetite, dizziness, vertigo, myalgias, insomnia, hoarseness, alopecia, sweating, reduced libido, and diarrhea | <10% |
| Psychologic and neurocognitive | |
| Post-traumatic stress disorder | 7 to 24% |
| Impaired memory | 18 to 21% |
| Poor concentration | 16% |
| Anxiety/depression | 22 to 23% |
| Reduction in quality of life | >50% |
COVID-19: coronavirus disease 2019.
* These data are derived from an earlier period in the pandemic. These figures may change as longer-term data emerge. Time course for recovery varies depending on premorbid risk factors and illness severity, and symptoms may last as long as 3 years.
¶ More than a third of patients with COVID-19 experience more than one persistent symptom.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
